Literature DB >> 20942847

Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

A C Mauer1, N A Khazanov, N Levenkova, S Tian, E M Barbour, C Khalida, J N Tobin, B S Coller.   

Abstract

BACKGROUND: Comparing a patient's bleeding symptoms with those of healthy individuals is an important component of the diagnosis of bleeding disorders, but little is known about whether bleeding symptoms in healthy individuals vary by sex, race, ethnicity, age, or aspirin use. OBJECTIVES, PATIENTS/
METHODS: We developed a comprehensive, ontology-backed, Web-based questionnaire to collect bleeding histories from 500 healthy adults. The mean age was 43 years (range 19-86 years), 63% were female, 19% were Hispanic, 37% were African-American, 43% were Caucasian, 8% were Asian, and 4% were multiracial.
RESULTS: 18 of the 36 symptoms captured occurred with < 5% frequency, and 26% of participants reported no bleeding symptoms (range 0-19 symptoms). Differences in sex, race, ethnicity, aspirin use and age accounted for only 6-13% of the variability in symptoms. Although men reported fewer symptoms than women (median 1 vs. 2, P < 0.01), there was no difference when sex-specific questions were excluded (median 1 for both men and women, P = 0.50). However, women reported more easy bruising (24% vs. 7%, P < 0.01) and venipuncture-related bruising (10% vs. 3%, P = 0.02). The number of symptoms did not vary by race or age, but epistaxis was reported more frequently by Caucasians than by African-Americans (29% vs. 18%, P = 0.02), and epistaxis frequency decreased with age (odds ratio 0.97 per year, P < 0.01). Paradoxically, infrequent aspirin users reported more bruising and heavy menses than frequent users (21% vs. 8%, P = 0.01, and 56% vs. 38%, P = 0.03, respectively).
CONCLUSIONS: Our findings provide a contemporaneous and comprehensive description of bleeding symptoms in a diverse group of healthy individuals. Our Web-based system is freely available to other investigators.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20942847      PMCID: PMC3017649          DOI: 10.1111/j.1538-7836.2010.04105.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  30 in total

1.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

Authors:  F Rodeghiero; G Castaman; A Tosetto; J Batlle; F Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; A B Federici; S Lethagen; S Linari; A Srivastava
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

3.  Is admission for epistaxis more common in Caucasian than in Asian people? A preliminary study.

Authors:  M Daniel; M C Jaberoo; R E Stead; V M Reddy; A A Moir
Journal:  Clin Otolaryngol       Date:  2006-10       Impact factor: 2.597

4.  Frequency of inherited bleeding disorders in women with menorrhagia.

Authors:  R A Kadir; D L Economides; C A Sabin; D Owens; C A Lee
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.

Authors:  Teresa Quiroga; Manuela Goycoolea; Olga Panes; Eduardo Aranda; Carlos Martínez; Sabine Belmont; Blanca Muñoz; Pamela Zúñiga; Jaime Pereira; Diego Mezzano
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

6.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  Bleeding disorders among young women: a population-based prevalence study.

Authors:  Britt Friberg; Ann Kristin Ornö; Annika Lindgren; Stefan Lethagen
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

8.  Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  D Green; K J Ruth; A R Folsom; K Liu
Journal:  Arterioscler Thromb       Date:  1994-05

9.  Bleeding in carriers of hemophilia.

Authors:  Iris Plug; Eveline P Mauser-Bunschoten; Annette H J T Bröcker-Vriends; Hans Kristian Ploos van Amstel; Johanna G van der Bom; Joanna E M van Diemen-Homan; José Willemse; Frits R Rosendaal
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

10.  Usefulness of patient interview in bleeding disorders.

Authors:  A Srámek; J C Eikenboom; E Briët; J P Vandenbroucke; F R Rosendaal
Journal:  Arch Intern Med       Date:  1995-07-10
View more
  15 in total

Review 1.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.

Authors:  P James; O Salomon; D Mikovic; F Peyvandi
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

3.  Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.

Authors:  Jon D Blumenfeld; Jeffrey Tepler; Andreas Mauer; Barry Coller; Daniel G Bichet; Barry Smith
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 4.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 5.  Phenotyping bleeding.

Authors:  Paula James; Barry S Coller
Journal:  Curr Opin Hematol       Date:  2012-09       Impact factor: 3.284

6.  Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project.

Authors:  M Elbatarny; S Mollah; J Grabell; S Bae; M Deforest; A Tuttle; W Hopman; D S Clark; A C Mauer; M Bowman; J Riddel; P A Christopherson; R R Montgomery; M L Rand; B Coller; P D James
Journal:  Haemophilia       Date:  2014-09-06       Impact factor: 4.287

7.  Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding.

Authors:  Allison Paroskie; Olatunde Oso; Benjamin Almassi; Michael R DeBaun; Robert F Sidonio
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

8.  The Role of Bleeding History and Clinical Markers for the Correct Diagnosis of VWD.

Authors:  Alberto Tosetto
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-12       Impact factor: 2.576

9.  Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice.

Authors:  Minka J Vries; Paola E van der Meijden; Gerhardus J Kuiper; Patricia J Nelemans; Rick J Wetzels; René G van Oerle; Marcus D Lancé; Hugo Ten Cate; Yvonne M Henskens
Journal:  Res Pract Thromb Haemost       Date:  2018-07-27

10.  Diagnostic work up of patients with increased bleeding tendency.

Authors:  Suzanne A M Zegers; Yolba Smit; Joline L Saes; Clint van Duren; Tim J Schuijt; Waander L van Heerde; Saskia E M Schols
Journal:  Haemophilia       Date:  2019-12-30       Impact factor: 4.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.